Analyst Rating Update on Bruker Corporation (BRKR)

Bruker Corporation (BRKR) : The consensus on Bruker Corporation (BRKR) based on 10 analyst recommendation on the company stock is 2.3, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 4 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 1 analyst also believes that the downside risk to the stock is higher and suggests a Sell on Bruker Corporation (BRKR).

Bruker Corporation (BRKR) : The highest short term price target forecast on Bruker Corporation (BRKR) is $34 and the lowest target price is $25. A total of 8 equity analysts are currently covering the company. The average price of all the analysts is $28.75 with a standard deviation of $3.06.

Company shares have received an average consensus rating of Hold for the current week Also, BTIG Research assumes its view on Bruker Corporation (NASDAQ:BRKR) according to the research report released by the firm to its investors. The shares have now been rated Neutral by the stock experts at the ratings house. The rating by the firm was issued on July 22, 2016.


Bruker Corporation (NASDAQ:BRKR): The stock opened at $22.50 on Wednesday but the bulls could not build on the opening and the stock topped out at $22.93 for the day. The stock traded down to $21.38 during the day, due to lack of any buying support eventually closed down at $21.79 with a loss of -11.85% for the day. The stock had closed at $24.72 on the previous day. The total traded volume was 4,864,030 shares.

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America, and it has sales offices located throughout the world.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.